TritiaReinaYamasakiMDPhD

PubMed

• 1 citations
  Visualization of the Movement Disorder Society Unified Parkinson's Disease Rating Scale Results.
  Jaimie Hixson, Jorge E Quintero, Ashley Guiliani, Tritia R Yamasaki, Greg A Gerhardt
  Journal of Parkinson's Disease. 2023-01-01
• 5 citations
  Analysis of circulating metabolites to differentiate Parkinson's disease and essential tremor.
  Elena A Ostrakhovitch, Eun-Suk Song, Jessica K A Macedo, Matthew S Gentry, Jorge E Quintero
  Neuroscience Letters. 2022-01-19
• Gait and Balance Changes with Investigational Peripheral Nerve Cell Therapy during Deep Brain Stimulation in People with Parkinson's Disease.
  Geetanjali Gera, Zain Guduru, Tritia R. Yamasaki, Julie A. Gurwell, Monica Chau
  Brain Sciences. 2021-04-15

Journal Articles

• Parkinson’s Disease and Multiple System Atrophy Have Distinct Α-synuclein Seed Characteristics  
  Brandon B. Holmes, Tritia R. Yamasaki, Marc I. Diamond, Nigel J. Cairns, Paul T. Kotzbauer, The Journal of Biological Chemistry
• Proteopathic tau seeding predicts tauopathy in vivo.  
  Holmes BB, Furman JL, Mahan TE, Yamasaki TR, Mirbaha H, Eades WC, Belaygorod L, Cairns NJ, Holtzman DM, Diamond MI., Proc Natl Acad Sci U S A
• Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's disease.  
  Teng E, Yamasaki TR, Tran M, Hsiao JJ, Sultzer DL, Mendez MF., Dement Geriatr Cogn Disord, 12/2013
• Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.  
  Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM., Proc Natl Acad Sci U S A, 7/2009
• Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.  
  Lopes JP, Blurton-Jones M, Yamasaki TR, Agostinho P, LaFerla FM., J Alzheimers Dis, 2009
• Neural stem cells improve memory in an inducible mouse model of neuronal loss.  
  Yamasaki TR, Blurton-Jones M, Morrissette DA, Kitazawa M, Oddo S, LaFerla FM., J Neurosci., 10/2007
• Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.  
  Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM., J Neurosci, 9/2005
• Microglia as a potential bridge between the amyloid beta-peptide and tau.  
  Kitazawa M, Yamasaki TR, LaFerla FM., Ann N Y Acad Sci, 12/2004
• Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.  
  Sugarman MC, Yamasaki TR, Oddo S, Echegoyen JC, Murphy MP, Golde TE, Jannatipour M, Leissring MA, LaFerla FM., Proc Natl Acad Sci U S A., 4/2002
• Calsenilin reverses presenilin-mediated enhancement of calcium signaling.  
  Leissring MA, Yamasaki TR, Wasco W, Buxbaum JD, Parker I, LaFerla FM., Proc Natl Acad Sci U S A., 7/2000
• Join now to see all